Protherics PLC
Notification of Major Interests in Shares
London, UK; Brentwood, TN, US: 21 December 2007 - Protherics PLC ("Protherics"
or the "Company"), the international biopharmaceutical company focused on
critical care and cancer, announces that on 20 December 2007, in accordance with
the Transparency Obligations Directive, a notification of interest in the
ordinary share capital of the Company was received from AXA Investment Managers
UK Limited on behalf of AXA S.A. and its Group Companies ("AXA"). The
notification follows an increase in the Indirect holding of AXA. Details of the
interest notified are as follows:
1. Reason for the notification (please tick the appropriate box or boxes)
An acquisition of voting rights X
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):
2. Full name of person(s) subject to the AXA S.A., 25 Avenue Matignon, 75008 Paris and its
notification obligation: group of companies.
3. Full name of shareholder(s) (if different
from 2.):
4. Date of the transaction (and date on which 18 December 2007
the threshold is crossed or reached if
different):
5. Date on which issuer notified: 19 December 2007
6. Threshold(s) that is/are crossed or reached: 14%
7. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous to Resulting situation after the triggering transaction
shares the Triggering
transaction
if possible using Number of Number of Number of Number of voting rights % of voting rights
the ISIN CODE Shares Voting shares
Rights Direct Direct Indirect Direct Indirect
0702920 43,726,012 43,726,012 741,666 741,666 48,854,003 0.22% 14.36%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ Conversion Number of voting rights % of voting rights
instrument Period/ Date that may be acquired if
the instrument is
exercised/ converted.
Total (A+B)
Number of voting rights % of voting rights
49,595,669 14.58%
8. Chain of controlled undertakings through which the voting rights and/or the financial instruments are
effectively held, if applicable :
Name of Company/Fund Number of Shares % of issued share capital
AXA UK Investment Co ICVC 551,929 0.16224
UK Smaller Companies Fund
Indirect
Sun Life Pensions Management Ltd 25,000 0.00735
Direct
Sun Life Unit Assurance Ltd 53,913 0.01585
FTSE All Share Tracker
Direct
Sun Life Pensions Management 294,874 0.08668
FTSE All Share Tracker
Direct
AXA Framlington 750,000 0.22046
SEI UK Equity
Indirect
AXA Framlington 1,600,000 0.47031
St James Place Exempt (Pens) Fund
Indirect
AXA Framlington 1,800,000 0.52910
St James Place Net (Life) Fund
Indirect
AXA Framlington 400,000 0.11758
St James Place Offshore Fund
Indirect
AXA Framlington 600,000 0.17637
Daimler Chrysler
Indirect
AXA Framlington 3,120,333 0.91720
Throgmorton Trust
Indirect
AXA Framlington 15,013,453 4.41308
UK Select Ops
Indirect
AXA Framlington 13,753,131 4.04262
Equity Income
Indirect
AXA Framlington 2,000,000 0.58788
Managed Balanced
Indirect
AXA Framlington 1,500,000 0.44091
UK Smaller Companies
Indirect
AXA Framlington 500,000 0.14697
BAE Systems Pensions Fund CIF Trustees
Indirect
AXA Framlington 220,000 0.06467
BAE Systems 2000 Pensions Fund
Indirect
Framlington onshore private clients 6,820,157 2.00473
Indirect
Axa Sun Life With Profits Passive 226,817 0.06667
Direct
Sun Life Ass With Profits Passive 141,062 0.04146
Direct
AXA Framlington
St James Place Internal
Equity & Income UT 225,000 0.06614
Indirect
Total Direct 741,666 0.21801
Total Indirect 48,854,003 14.36024
TOTAL 49,595,669 14.57825
Proxy Voting:
9. Name of the proxy holder:
10. Number of voting rights proxy holder will cease to hold:
11. Date on which proxy holder will cease to hold voting
rights:
12. Additional information:
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
Protherics PLC - Notification of Major Interests in Shares
| Source: Protherics PLC
Cheshire, UK--(Marketwire - December 21, 2007) -